Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study

Christopher Keary*, Lynne M. Bird, Marie Claire de Wit, Shivkumar Hatti, Gali Heimer, Helen Heussler, Alexander Kolevzon, Adera Mathews, Cesar Ochoa-Lubinoff, Wen Hann Tan, Ying Yan, Maxwell Adams

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences